Cannabis News Cannabis TV
  FDA Approves Marijuana Study On Migraines
Posted by FoM on October 09, 1999 at 09:22:14 PT
NORML's Weekly Update News 
Source: NORML 

NORML Oct. 7, 1999, Missoula, MT: The Food and Drug Administration has granted approval to Ethan Russo, MD, a Montana neurologist, to study the effects of smoked marijuana as compared to oral dronabinol (Marinol(R)) and injected sumatriptan (Imitrex(R)) in the treatment of migraine headaches.

Russo will enroll 40 patients with severe migraines, and employ a double-blind, double-dummy crossover design (neither the patients nor examiners will know whether they are employing real cannabis or THC-free cannabis or true dronabinol or a placebo).

The study still faces a roadblock in the National Institute on Drug Abuse (NIDA). NIDA, the only American supplier of research marijuana, has recently changed its policy and will only provide marijuana to researchers whose studies have gained FDA approval as well as a NIDA Public Health Service review.

"NIDA has added a new hoop through which cannabis researchers must jump," Russo said. "For any other substance, even cocaine or heroin, approval of an Investigative New Drug (IND) application by FDA allows the researcher to proceed directly to clinical trials. NIDA has thrown up a new and unnecessary barrier to this research."

If NIDA demands changes in the protocol, Russo would need to file another IND application with the FDA which would cause further delays. In the meantime, the delay hinders Russo's ability to raise funding from private sources for the projected $250,000 study.

"Ethan's chances of obtaining approval for his marijuana/migraine study from NIDA's Public Health Service review are very good, simply because NIDA needs to show that it isn't blocking research," said Rick Doblin, President of Multidisciplanary Association for Psychedelic Studies (MAPS).

"For me the most intriguing question is not whether the protocol will be approved but what will NIDA charge for one pound of its low potency pot, which is all that Ethan needs for his study."

For more information, please contact:

Ethan Russo, MD
at (406) 327-3372
or Rick Doblin,
President of MAPS at (617) 484-8711.

NORML's News Bulletin:

FDA-Approved Marijuana Study At Last Hurdle


National Institute on Drug Abuse

Marijuana & The Migraine - Research

Medical Marijuana Research

Cannabis News NORML Articles:

Home    Comment    Email    Register    Recent Comments    Help

  Post Comment
Name:       Optional Password:


Comment:   [Please refrain from using profanity in your message]

Link URL:
Link Title:

Return to Main Menu

So everyone may enjoy this service and to keep it running, here are some guidelines: NO spamming, NO commercial advertising, NO flamming, NO illegal activity, and NO sexually explicit materials. Lastly, we reserve the right to remove any message for any reason!

This web page and related elements are for informative purposes only and thus the use of any of this information is at your risk! We do not own nor are responsible for visitor comments. In accordance with Title 17 U.S.C. Section 107 and The Berne Convention on Literary and Artistic Works, Article 10, news clippings on this site are made available without profit for research and educational purposes. Any trademarks, trade names, service marks, or service names used on this site are the property of their respective owners. Page updated on October 09, 1999 at 09:22:14